Search research articles
Contact Us
Filters
Showing results (411-420 of 630) with videos related to
Page
of 63
Sort By:
Mayo Clinic Proceedings
|
March 13, 2002
A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer
Rosebud O Roberts, Debra J Jacobson, Cynthia J Girman, et al.
Biological Psychiatry
|
January 1, 1994
Early and late cognitive event-related potentials mark stages of HIV-1 infection in the drug-user risk group
M M Schroeder, L Handelsman, L Torres, et al.
Journal of Clinical Pharmacology
|
October 5, 2001
Pharmacokinetics and pharmacodynamics of thalidomide in HIV patients treated for oral aphthous ulcers: ACTG protocol 251. AIDS Clinical Trials Group
F Aweeka, C Trapnell, M Chernoff, et al.
Nature
|
September 4, 1980
Involvement of the B-lymphoid system in chronic myelogenous leukaemia
P J Martin, V Najfeld, J A Hansen, et al.
Preventive Medicine Reports
|
August 17, 2021
Barriers to utilization of three colorectal cancer screening options - Data from a national survey
Xuan Zhu, Philip D Parks, Emily Weiser, et al.
Urology
|
February 25, 2003
Frequency of sexual activity and prostatic health: fact or fairy tale?
Steven J Jacobsen, Debra J Jacobson, Daniel E Rohe, et al.
ACS Applied Materials & Interfaces
|
April 2, 2010
Gold, palladium, and gold-palladium alloy nanoshells on silica nanoparticle cores
Jun-Hyun Kim, William W Bryan, Hae-Won Chung, et al.
Blood
|
July 1, 1980
Philadelphia chromosome (Ph1)-negative chronic myelogenous leukemia (CML): a clonal disease with origin in a multipotent stem cell
P J Fialkow, R J Jacobson, J W Singer, et al.
Blood
|
October 1, 1978
Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer
R G Wiggans, R J Jacobson, P J Fialkow, et al.
Population Health Management
|
October 1, 2016
Incidence Rate of Prediabetes Progression to Diabetes: Modeling an Optimum Target Group for Intervention
Ramona S DeJesus, Carmen Radecki Breitkopf, Lila J Rutten, et al.
Page
of 63
Search research articles
Search
Showing results (411-420 of 630) with videos related to
Sort By:
Page
of 63
Mayo Clinic Proceedings
|
March 13, 2002
A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer
Rosebud O Roberts, Debra J Jacobson, Cynthia J Girman, et al.
Biological Psychiatry
|
January 1, 1994
Early and late cognitive event-related potentials mark stages of HIV-1 infection in the drug-user risk group
M M Schroeder, L Handelsman, L Torres, et al.
Journal of Clinical Pharmacology
|
October 5, 2001
Pharmacokinetics and pharmacodynamics of thalidomide in HIV patients treated for oral aphthous ulcers: ACTG protocol 251. AIDS Clinical Trials Group
F Aweeka, C Trapnell, M Chernoff, et al.
Nature
|
September 4, 1980
Involvement of the B-lymphoid system in chronic myelogenous leukaemia
P J Martin, V Najfeld, J A Hansen, et al.
Preventive Medicine Reports
|
August 17, 2021
Barriers to utilization of three colorectal cancer screening options - Data from a national survey
Xuan Zhu, Philip D Parks, Emily Weiser, et al.
Urology
|
February 25, 2003
Frequency of sexual activity and prostatic health: fact or fairy tale?
Steven J Jacobsen, Debra J Jacobson, Daniel E Rohe, et al.
ACS Applied Materials & Interfaces
|
April 2, 2010
Gold, palladium, and gold-palladium alloy nanoshells on silica nanoparticle cores
Jun-Hyun Kim, William W Bryan, Hae-Won Chung, et al.
Blood
|
July 1, 1980
Philadelphia chromosome (Ph1)-negative chronic myelogenous leukemia (CML): a clonal disease with origin in a multipotent stem cell
P J Fialkow, R J Jacobson, J W Singer, et al.
Blood
|
October 1, 1978
Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer
R G Wiggans, R J Jacobson, P J Fialkow, et al.
Population Health Management
|
October 1, 2016
Incidence Rate of Prediabetes Progression to Diabetes: Modeling an Optimum Target Group for Intervention
Ramona S DeJesus, Carmen Radecki Breitkopf, Lila J Rutten, et al.
Page
of 63